The β-Secretase 1 Enzyme As a Novel Therapeutic Target for Prostate Cancer

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Jan 11

PMID 38201438

Authors

Hilal A Rather

Sameh Almousa

Ashish Kumar

Mitu Sharma

Isabel Pennington

Susy Kim

Yixin Su

Yangen He

Abdollah R Ghara

Kiran Kumar Solingapuram Sai

Nora M Navone

Donald J Vander Griend

Gagan Deep

Affiliations

Soon will be listed here.

Abstract

Recent studies have demonstrated the association of APP and Aβ with cancer, suggesting that BACE1 may play an important role in carcinogenesis. In the present study, we assessed BACE1's usefulness as a therapeutic target in prostate cancer (PCa). BACE1 expression was observed in human PCa tissue samples, patient-derived xenografts (PDX), human PCa xenograft tissue in nude mice, and transgenic adenocarcinoma of the mouse prostate (TRAMP) tissues by immunohistochemistry (IHC) analysis. Additionally, the downstream product of BACE1 activity, i.e., Aβ1-42 expression, was also observed in these PCa tissues by IHC as well as by PET imaging in TRAMP mice. Furthermore, BACE1 gene expression and activity was confirmed in several established PCa cell lines (LNCaP, C4-2B-enzalutamide sensitive [S], C4-2B-enzalutamide resistant [R], 22Rv1-S, 22Rv1-R, PC3, DU145, and TRAMP-C1) by real-time PCR and fluorometric assay, respectively. Treatment with a pharmacological inhibitor of BACE1 (MK-8931) strongly reduced the proliferation of PCa cells in in vitro and in vivo models, analyzed by multiple assays (MTT, clonogenic, and trypan blue exclusion assays and IHC). Cell cycle analyses revealed an increase in the sub-G1 population and a significant modulation in other cell cycle stages (G1/S/G2/M) following MK-8931 treatment. Most importantly, in vivo administration of MK-8931 intraperitoneal (30 mg/kg) strongly inhibited TRAMP-C1 allograft growth in immunocompetent C57BL/6 mice (approximately 81% decrease, = 0.019). Furthermore, analysis of tumor tissue using the prostate cancer-specific pathway array revealed the alteration of several genes involved in PCa growth and progression including Forkhead O1 (FOXO1). All together, these findings suggest BACE1 as a novel therapeutic target in advanced PCa.

References

Lim S, Yoo B, Kim H, Gilmore H, Lee Y, Lee H . Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer. BMC Cancer. 2014; 14:928. PMC: 4295427. DOI: 10.1186/1471-2407-14-928. View

Zhai K, Huang Z, Huang Q, Tao W, Fang X, Zhang A . Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells. Nat Cancer. 2022; 2(11):1136-1151. PMC: 8809483. DOI: 10.1038/s43018-021-00267-9. View

Singer O, Marr R, Rockenstein E, Crews L, Coufal N, Gage F . Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci. 2005; 8(10):1343-9. DOI: 10.1038/nn1531. View

Zhang W, Bai S, Yang J, Zhang Y, Liu Y, Nie J . FoxO1 overexpression reduces Aβ production and tau phosphorylation in vitro. Neurosci Lett. 2020; 738:135322. DOI: 10.1016/j.neulet.2020.135322. View

Zayas-Santiago A, Martinez-Montemayor M, Colon-Vazquez J, Ortiz-Soto G, Cirino-Simonet J, Inyushin M . Accumulation of amyloid beta (Aβ) and amyloid precursor protein (APP) in tumors formed by a mouse xenograft model of inflammatory breast cancer. FEBS Open Bio. 2021; 12(1):95-105. PMC: 8727955. DOI: 10.1002/2211-5463.13308. View

Meethal S, Smith M, Bowen R, Atwood C . The gonadotropin connection in Alzheimer's disease. Endocrine. 2005; 26(3):317-26. DOI: 10.1385/ENDO:26:3:317. View

Yi J, Zhu J, Wu J, Thompson C, Jiang X . Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A. 2020; 117(49):31189-31197. PMC: 7733797. DOI: 10.1073/pnas.2017152117. View

Hong Y, Beckett C, Belyaev N, Turner A . The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells. Int J Cancer. 2011; 130(4):775-86. DOI: 10.1002/ijc.26028. View

Zhang W, Bai S, Zhang Q, Shi R, Wang H, Liu Y . Physalin B reduces Aβ secretion through down-regulation of BACE1 expression by activating FoxO1 and inhibiting STAT3 phosphorylation. Chin J Nat Med. 2021; 19(10):732-740. DOI: 10.1016/S1875-5364(21)60090-0. View

10.

OBrien R, Wong P . Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci. 2011; 34:185-204. PMC: 3174086. DOI: 10.1146/annurev-neuro-061010-113613. View

11.

Li M, Pehar M, Liu Y, Bhattacharyya A, Zhang S, ORiordan K . The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism. Neurobiol Aging. 2015; 36(10):2725-36. PMC: 4562799. DOI: 10.1016/j.neurobiolaging.2015.06.021. View

12.

Kleffman K, Levinson G, Rose I, Blumenberg L, Shadaloey S, Dhabaria A . Melanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis. Cancer Discov. 2022; 12(5):1314-1335. PMC: 9069488. DOI: 10.1158/2159-8290.CD-21-1006. View

13.

Bhaskar K, Miller M, Chludzinski A, Herrup K, Zagorski M, Lamb B . The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events. Mol Neurodegener. 2009; 4:14. PMC: 2663563. DOI: 10.1186/1750-1326-4-14. View

14.

Cham J, Venkateswaran A, Bhangoo M . Targeting the PI3K-AKT-mTOR Pathway in Castration Resistant Prostate Cancer: A Review Article. Clin Genitourin Cancer. 2021; 19(6):563.e1-563.e7. DOI: 10.1016/j.clgc.2021.07.014. View

15.

Farris F, Matafora V, Bachi A . The emerging role of β-secretases in cancer. J Exp Clin Cancer Res. 2021; 40(1):147. PMC: 8082908. DOI: 10.1186/s13046-021-01953-3. View

16.

Kato M, Banuelos C, Imamura Y, Leung J, Caley D, Wang J . Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer. Clin Cancer Res. 2015; 22(11):2744-54. PMC: 4891302. DOI: 10.1158/1078-0432.CCR-15-2119. View

17.

Miyazaki T, Ikeda K, Horie-Inoue K, Inoue S . Amyloid precursor protein regulates migration and metalloproteinase gene expression in prostate cancer cells. Biochem Biophys Res Commun. 2014; 452(3):828-33. DOI: 10.1016/j.bbrc.2014.09.010. View

18.

Chow V, Mattson M, Wong P, Gleichmann M . An overview of APP processing enzymes and products. Neuromolecular Med. 2010; 12(1):1-12. PMC: 2889200. DOI: 10.1007/s12017-009-8104-z. View

19.

Bowen R, Verdile G, Liu T, Parlow A, Perry G, Smith M . Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem. 2004; 279(19):20539-45. DOI: 10.1074/jbc.M311993200. View

20.

Kucheryavykh L, Ortiz-Rivera J, Kucheryavykh Y, Zayas-Santiago A, Diaz-Garcia A, Inyushin M . Accumulation of Innate Amyloid Beta Peptide in Glioblastoma Tumors. Int J Mol Sci. 2019; 20(10). PMC: 6567111. DOI: 10.3390/ijms20102482. View